PROVAG vaginal ovules
Natural health product licensed in Canada
- Other names
- PROVAG Women's probiotic 5B vaginal ovules
- Licence holder
- Prébionature Inc.
- NPN or DIN-HM
- 80144275
- Status
- Active licence
- Licence date
- 19 September 2025
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Vaginale
- Application type
- Générale (non traditionelle)
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Lactiplantibacillus plantarum Source : Lactiplantibacillus Plantarum - Cellule entière | 1 Milliards d'UFC |
| Lactiplantibacillus plantarum Source : PBS067 (LP080) | 1 Milliards d'UFC |
| Lacticaseibacillus rhamnosus Source : LRH020 | 1 Milliards d'UFC |
Non-medicinal ingredients
Lactose, Ascorbate de sodium, Maltodextrine, L-Cystéine, Hypromellose, Sucrose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Population not specified | Not specified | 1 Capsule | 1 Tous les jours |
| Femmes | minimum: 18 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to support feminine health. Helps naturally maintain/promote feminine health. Helps (to) maintain feminine/vaginal health. Clinically shown to help support vaginal health. Clinically shown to help support feminine health. Helps maintain healthy vaginal flora. Could promote a favorable vaginal flora. Source of Probiotics. Helps relieve dryness and promote healing of vaginal mucosa in menopausal women. Helps improve epithelial atrophy and increases maturation of the vaginal epithelium in postmenopausal women. Helps relieve vaginal dryness and contributes to the maintenance of healthy vaginal mucosa and pH in postmenopausal women. Helps relieve symptoms associated with vaginal atrophy, such as vaginal dryness, pain, irritation/itching, burning and painful sexual activity (dyspaneuria) in postmenopausal women.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80144275
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.